Rekah Pharmaceutical Industry Ltd. (TLV:REKA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,131.00
+33.00 (3.01%)
Jan 6, 2026, 5:24 PM IDT
-15.97%
Market Cap125.33M
Revenue (ttm)300.24M
Net Income (ttm)-14.11M
Shares Out11.41M
EPS (ttm)-1.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume846
Average Volume4,287
Open1,098.00
Previous Close1,098.00
Day's Range1,098.00 - 1,133.00
52-Week Range1,044.00 - 1,498.00
Beta0.02
RSI46.82
Earnings DateMar 26, 2026

About TLV:REKA

Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of pharmaceuticals, cosmetics, vitamins and nutritional supplements, and medical devices in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise generic Rx and OTC drugs used in various therapeutic fields, such as urinary tract pain, steroid anti-in... [Read more]

Sector Healthcare
Founded 1947
Employees 421
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol REKA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.